These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 2142092)

  • 1. Pentobarbital anaesthesia prevents the adrenaline-releasing effect of the 5-HT1A receptor agonist, 8-hydroxy-2-(di-n-propylamino) tetralin.
    Chaouloff F; Baudrie V; Laude D
    Eur J Pharmacol; 1990 May; 180(1):175-8. PubMed ID: 2142092
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evidence that 5-HT1A receptors are involved in the adrenaline-releasing effects of 8-OH-DPAT in the conscious rat.
    Chaouloff F; Baudrie V; Laude D
    Naunyn Schmiedebergs Arch Pharmacol; 1990 Apr; 341(4):381-4. PubMed ID: 1970616
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiovascular and adrenaline-releasing effects of the 5-HT1A receptor agonist 8-hydroxy-2-(di-n-propylamino)tetralin in streptozotocin diabetic rats.
    Chaouloff F; Blanc J; Baudrie V; Laude D; Elghozi JL
    Life Sci; 1991; 48(26):2543-52. PubMed ID: 1828521
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Marked increases in plasma catecholamine concentrations precede hypotension and bradycardia caused by 8-hydroxy-2-(di-n-propylamino) tetralin (8-OH-DPAT) in conscious rats.
    Bagdy G; Szemeredi K; Murphy DL
    J Pharm Pharmacol; 1989 Apr; 41(4):270-2. PubMed ID: 2568470
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ganglionic transmission is a prerequisite for the adrenaline-releasing and hyperglycemic effects of 8-OH-DPAT.
    Chaouloff F; Laude D; Baudrie V
    Eur J Pharmacol; 1990 Aug; 185(1):11-8. PubMed ID: 2171956
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hyperinsulinemia of the genetically obese (fa/fa) rat is decreased by a low dose of the 5-HT1A receptor agonist 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT).
    Chaouloff F; Jeanrenaud B
    Eur J Pharmacol; 1988 Feb; 147(1):111-8. PubMed ID: 2967189
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Repeated treatment with the 5-HT1A receptor agonist, ipsapirone, does not affect 8-OH-DPAT- and stress-induced increases in plasma adrenaline levels in the rat.
    Baudrie V; Chaouloff F
    Eur J Pharmacol; 1991 Jun; 198(2-3):129-35. PubMed ID: 1830845
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 5-HT1A and alpha-2 adrenergic receptors mediate the hyperglycemic and hypoinsulinemic effects of 8-hydroxy-2-(di-n-propylamino)tetralin in the conscious rat.
    Chaouloff F; Jeanrenaud B
    J Pharmacol Exp Ther; 1987 Dec; 243(3):1159-66. PubMed ID: 2826757
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Investigation of the mechanism(s) of 8-OH-DPAT-mediated inhibition of plasma insulin in spontaneously hypertensive rats.
    Bouhelal R; Loubatières-Mariani MM; Mir AK
    Br J Pharmacol; 1990 May; 100(1):173-9. PubMed ID: 2142614
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiovascular response to 8-hydroxy-2-(di-n-propylamino) tetralin (8-OH-DPAT) in the rat: site of action and pharmacological analysis.
    Fozard JR; Mir AK; Middlemiss DN
    J Cardiovasc Pharmacol; 1987 Mar; 9(3):328-47. PubMed ID: 2437400
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of the cardiovascular effects of the 5-HT1A receptor agonist flesinoxan with that of 8-OH-DPAT in the rat.
    Dreteler GH; Wouters W; Saxena PR
    Eur J Pharmacol; 1990 May; 180(2-3):339-49. PubMed ID: 2142096
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mediation of the discriminative stimulus properties of 8-hydroxy-2-(di-n-propylamino) tetralin (8-OH-DPAT) by the putative 5-HT1A receptor.
    Tricklebank MD; Neill J; Kidd EJ; Fozard JR
    Eur J Pharmacol; 1987 Jan; 133(1):47-56. PubMed ID: 2881789
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Behavioural effects of 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT) in monkeys.
    Mizuta E; Yamaguchi M; Kuno S
    Eur J Pharmacol; 1990 Mar; 178(1):125-7. PubMed ID: 2139614
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Partial postsynaptic 5-HT1A agonist properties of the novel stereoselective 8-OH-DPAT analogue (+)cis-8-hydroxy-1-methyl-2-(di-n-propylamino)tetralin, (+)ALK-3.
    Hjorth S; Sharp T; Hacksell U
    Eur J Pharmacol; 1989 Nov; 170(3):269-74. PubMed ID: 2533557
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anticonflict effect of the putative serotonin receptor agonist 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT).
    Engel JA; Hjorth S; Svensson K; Carlsson A; Liljequist S
    Eur J Pharmacol; 1984 Oct; 105(3-4):365-8. PubMed ID: 6239785
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The long-term effects of 8-hydroxy-2-(di-n-propyl-amino)tetralin (8-OH-DPAT) on copulatory and exploratory behaviour in male rats.
    Johansson CE; Meyerson BJ; Höglund AU
    Eur J Pharmacol; 1990 Mar; 178(1):1-9. PubMed ID: 2139613
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased population spike amplitude in the dentate gyrus following systemic administration of 5-hydroxytryptophan or 8-hydroxy-2-(di-n-propylamino)tetralin.
    Klancnik JM; Baimbridge KG; Phillips AG
    Brain Res; 1989 Dec; 505(1):145-8. PubMed ID: 2532947
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of route of administration on potency of the selective 5HT-1A agonist, 8-hydroxy-2-(di-n-propylamino)tetralin, in rats.
    Fuller RW; Snoddy HD
    Res Commun Chem Pathol Pharmacol; 1987 Dec; 58(3):409-12. PubMed ID: 2449711
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Involvement of 5-HT1A- and alpha 2-receptors in the decreased 5-hydroxytryptamine release and metabolism in rat suprachiasmatic nucleus after intravenous 8-hydroxy-2-(n-dipropylamino) tetralin.
    Marsden CA; Martin KF
    Br J Pharmacol; 1986 Oct; 89(2):277-86. PubMed ID: 2430656
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The behavioural effects of 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT) in mice.
    Yamada J; Sugimoto Y; Horisaka K
    Eur J Pharmacol; 1988 Sep; 154(3):299-304. PubMed ID: 2976671
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.